Health ❯Medicine ❯Endocrinology

Hormones

Anti-aging Treatments Amylin Non-Hormonal Birth Control

AbbVie Enters Obesity Drug Market with $2.2 Billion Licensing Deal

The pharmaceutical giant partners with Danish firm Gubra to develop an experimental amylin-based weight-loss treatment currently in Phase 1 trials.

Hormonal Research Suggests Potential Breakthroughs in Anti-Aging Treatments

Breakthrough in Male Contraception: Reversible, Non-Hormonal Method Discovered